PharmaCyte Biotech, Inc. PMCB

Set alert

Price alert · PMCB

All alert types
0.31 USD +0.01 +2.71%

At close · Nov 2

0.32 +0.01 +2.19%

After hours · Nov 2, 4:00 PM ET

Bid
0.29 × 2
Ask
0.32 × 2
0.31 Day range 0.32
0.3021 52-week range 1.51
YTD
-57.14%
1 year
-66.63%
Open
0.31
Prev close
0.3021
Mkt cap
3.33M
Vol
40.84K
Avg vol
183.73K
EPS
-2.31
P/E
0.00
Div yield
0.00%
More statistics
Low
0.31
High
0.32
Forward P/E
-4.21
Beta
-0.20
Short ratio
1.09
Inst. own
13.16%
Dividend
0.00
Ex-div date
50-d avg
1.73
200-d avg
1.94
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PMCB has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $240.68KExpenses → Selling, General & Admin: $1.69MExpenses → Interest Expense: $154.42KGross Profit → Expenses: $2.54KRevenue → Gross Profit: $2.54KRevenue → Cost of Revenue: $9.62KNet Loss → Expenses: $1.60MOther Income$240.68KGross Profit$2.54KNet Loss$1.60MCost of Revenue$9.62KExpenses$1.84MSelling, General & Admin$1.69MInterest Expense$154.42KRevenue$12.16K

Latest period ending Apr 30, 2026 · select a line to chart its full history

PMCB annual income statement
Fiscal yearFY 2026 Apr 30, 2026FY 2025 Apr 30, 2025FY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022
-6.85M-4.38M-8.52M-6.46M-4.39M
-19.42M30.66M333.76K-4.32M-4.24M
-2.773.19-1.80-0.22-0.27
PMCB annual balance sheet
Fiscal yearFY 2026 Apr 30, 2026FY 2025 Apr 30, 2025FY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022
18.60M15.17M50.18M68.04M85.40M
46.75M55.17M59.90M73.28M90.62M
11.77M3.28M20.39M586.58K704.37K
33.29M51.89M27.65M72.69M89.92M
PMCB annual cash flow
Fiscal yearFY 2026 Apr 30, 2026FY 2025 Apr 30, 2025FY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022
-5.15M-2.98M-2.15M-3.79M-4.12M
2.00M-7.00M-5.00M00
6.58M-25.03M-10.71M-13.56M87.31M
3.43M-35.01M-17.86M-17.36M83.20M